Van Dieren L, Quisenaerts T, Licata M, Beddok A, Lellouch A, Ysebaert D
Cancers (Basel). 2024; 16(21).
PMID: 39518094
PMC: 11545184.
DOI: 10.3390/cancers16213656.
Tsai T, Hwang T, Chen P, Chen Y, Chou K, Ho C
Int J Oncol. 2024; 65(6).
PMID: 39513598
PMC: 11575926.
DOI: 10.3892/ijo.2024.5704.
Ohguri T, Tani S, Kawarada Y, Kitahara M
Cureus. 2024; 16(9):e69147.
PMID: 39398851
PMC: 11467698.
DOI: 10.7759/cureus.69147.
Righini M, Durham A, Tsoutsou P
Front Oncol. 2024; 14:1428065.
PMID: 39165690
PMC: 11333208.
DOI: 10.3389/fonc.2024.1428065.
Han Y, Du Y, He L, Meng X, Li M, Cao F
Sensors (Basel). 2024; 24(15).
PMID: 39123982
PMC: 11314660.
DOI: 10.3390/s24154934.
Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System.
Wang H, Bo W, Feng X, Zhang J, Li G, Chen Y
Int J Nanomedicine. 2024; 19:5581-5603.
PMID: 38882543
PMC: 11177867.
DOI: 10.2147/IJN.S460844.
Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment.
Logghe T, van Zwol E, Immordino B, Van den Cruys K, Peeters M, Giovannetti E
Cancers (Basel). 2024; 16(3).
PMID: 38339258
PMC: 10854776.
DOI: 10.3390/cancers16030505.
Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve Radiosensitivity.
Shestovskaya M, Luss A, Bezborodova O, Makarov V, Keskinov A
Pharmaceutics. 2023; 15(10).
PMID: 37896166
PMC: 10610190.
DOI: 10.3390/pharmaceutics15102406.
Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia.
Zhang Y, Li Z, Huang Y, Zou B, Xu Y
Front Immunol. 2023; 14:1258786.
PMID: 37869003
PMC: 10587571.
DOI: 10.3389/fimmu.2023.1258786.
Biosynthesized gold nanoparticles that activate Toll-like receptors and elicit localized light-converting hyperthermia for pleiotropic tumor immunoregulation.
Qin H, Chen Y, Wang Z, Li N, Sun Q, Lin Y
Nat Commun. 2023; 14(1):5178.
PMID: 37620331
PMC: 10449932.
DOI: 10.1038/s41467-023-40851-4.
Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale.
Fernandez-Gomez P, Perez de la Lastra Aranda C, Tosat-Bitrian C, Bueso de Barrio J, Thompson S, Sot B
Front Bioeng Biotechnol. 2023; 11:1191327.
PMID: 37545884
PMC: 10401050.
DOI: 10.3389/fbioe.2023.1191327.
The Role of Hyperthermia in Potentiation of Anti-Angiogenic Effect of Cisplatin and Resveratrol in Mice Bearing Solid Form of Ehrlich Ascites Tumour.
Kucan D, Orsolic N, Odeh D, Ramic S, Jakopovic B, Knezevic J
Int J Mol Sci. 2023; 24(13).
PMID: 37446252
PMC: 10341868.
DOI: 10.3390/ijms241311073.
Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy.
Rupp L, Resag A, Potkrajcic V, Warm V, Wehner R, Johrens K
Front Immunol. 2023; 14:1185197.
PMID: 37261361
PMC: 10228739.
DOI: 10.3389/fimmu.2023.1185197.
HSP27 modulates tumoural immune evasion by enhancing STAT3-mediated upregulation of PD-L1 and NLRC5 in ovarian cancer.
Fezza M, Hilal G, Tahtouh R, Moubarak M, Atallah D
Ecancermedicalscience. 2023; 17:1526.
PMID: 37113720
PMC: 10129406.
DOI: 10.3332/ecancer.2023.1526.
Application of survival analysis to model proliferation likelihood of biofilm following laser-induced hyperthermia treatment.
Burden B, Rodriguez-Alvarez J, Levi N, Gayzik F
Front Bioeng Biotechnol. 2023; 11:1001017.
PMID: 36761303
PMC: 9903214.
DOI: 10.3389/fbioe.2023.1001017.
Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience.
Amin M, Seynhaeve A, Sharifi M, Falahati M, Ten Hagen T
Pharmaceutics. 2022; 14(10).
PMID: 36297598
PMC: 9607095.
DOI: 10.3390/pharmaceutics14102165.
The Immune Contexture of Liposarcoma and Its Clinical Implications.
Resag A, Toffanin G, Benesova I, Muller L, Potkrajcic V, Ozaniak A
Cancers (Basel). 2022; 14(19).
PMID: 36230502
PMC: 9559230.
DOI: 10.3390/cancers14194578.
Endothelial Cell Adhesion Molecules- (un)Attainable Targets for Nanomedicines.
Milosevic N, Rutter M, David A
Front Med Technol. 2022; 4:846065.
PMID: 35463298
PMC: 9021548.
DOI: 10.3389/fmedt.2022.846065.
Elucidating the Innate Immunological Effects of Mild Magnetic Hyperthermia on U87 Human Glioblastoma Cells: An In Vitro Study.
Persano S, Vicini F, Poggi A, Fernandez J, Rizzo G, Gavilan H
Pharmaceutics. 2021; 13(10).
PMID: 34683961
PMC: 8537446.
DOI: 10.3390/pharmaceutics13101668.
Efficient Heat Shock Response Affects Hyperthermia-Induced Radiosensitization in a Tumor Spheroid Control Probability Assay.
Chen O, Michlikova S, Eckhardt L, Wondrak M, De Mendoza A, Krause M
Cancers (Basel). 2021; 13(13).
PMID: 34201993
PMC: 8269038.
DOI: 10.3390/cancers13133168.